Heves Sürmeli

Pan‑immune‑inflammation value as a prognostic and predictive biomarker in metastatic non‑small cell lung cancer treated with nivolumab: A real‑world study

Nedi̇m Turan, Hacer Yildiz, Sedat Yildirim, Ezgi̇ Turkoglu et autres

tr, ag (code pays fourni par la source)

Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study

Sedat Yildirim, Özlem Nuray Sever, Ezgi Turkoglu, Nisanur Sariyar Busery et autres

tr, ag, bh, kh (code pays fourni par la source)

Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study

Sila Oksuz, Oguzcan Kınıkoglu, Nisanur Sariyar, Mert Ozdemir et autres

tr (code pays fourni par la source)

Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk–Stratified Analysis

Sila OKSUZ, Oguzcan Kinikoglu, Uğur Özkerim, Deniz Isik et autres

tr (code pays fourni par la source)

Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study

Akif Doğan, Sedat Yıldırım, Hande Nur Erölmez, Goncagül Akdağ et autres

us, tr (code pays fourni par la source)

Author response for "Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study"

Akif Dogan, Sedat Yildirim, Hande Nur Erölmez, Goncagül Akdağ et autres

Author response for "Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study"

Akif Dogan, Sedat Yildirim, Hande Nur Erölmez, Goncagül Akdağ et autres

Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma

Sila OKSUZ, Oguzcan Kinikoglu, Uğur Özkerim, Deniz Isik et autres

tr (code pays fourni par la source)

Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide

Uğur Özkerim, Oguzcan Kinikoglu, Deniz Isik, Yunus Emre Altıntaş et autres

tr (code pays fourni par la source)

Author response for "Prognostic Value of the Cancer Inflammation Prognostic Index (CIPI) in De Novo Metastatic Colon Cancer: A Multicenter Retrospective Cohort Study"

Akif Dogan, Sedat Yildirim, Hande Nur Erölmez, Goncagül Akdağ et autres

Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study

Uğur Özkerim, Oguzcan Kinikoglu, Sila OKSUZ, Deniz Isik et autres

tr (code pays fourni par la source)

Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study

Uğur Özkerim, Deniz Isik, Oguzcan Kinikoglu, Sila OKSUZ et autres

tr (code pays fourni par la source)